Correlation Between Elevation Oncology and Ardelyx
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Ardelyx, you can compare the effects of market volatilities on Elevation Oncology and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Ardelyx.
Diversification Opportunities for Elevation Oncology and Ardelyx
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Elevation and Ardelyx is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Ardelyx go up and down completely randomly.
Pair Corralation between Elevation Oncology and Ardelyx
Given the investment horizon of 90 days Elevation Oncology is expected to generate 0.87 times more return on investment than Ardelyx. However, Elevation Oncology is 1.16 times less risky than Ardelyx. It trades about 0.05 of its potential returns per unit of risk. Ardelyx is currently generating about 0.01 per unit of risk. If you would invest 60.00 in Elevation Oncology on August 31, 2024 and sell it today you would earn a total of 2.00 from holding Elevation Oncology or generate 3.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Elevation Oncology vs. Ardelyx
Performance |
Timeline |
Elevation Oncology |
Ardelyx |
Elevation Oncology and Ardelyx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Elevation Oncology and Ardelyx
The main advantage of trading using opposite Elevation Oncology and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.Elevation Oncology vs. Cue Biopharma | Elevation Oncology vs. Eliem Therapeutics | Elevation Oncology vs. Inhibrx | Elevation Oncology vs. Molecular Partners AG |
Ardelyx vs. Cue Biopharma | Ardelyx vs. Eliem Therapeutics | Ardelyx vs. Inhibrx | Ardelyx vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |